Axerion Therapeutics Inc. in Branford are in the end of pre clinical testing of the NgR1 Protein for CHRONIC spinal cord injury. They were now elected from the National Institute for Health (NIH) for supporting this treatment and for getting it forward to human clinical trials. They had some good pre clinical results with this treatment.

Lets wait and see!!